טוען...
Novel Agents for the Treatment of Type 2 Diabetes
In Brief Impaired insulin secretion, increased hepatic glucose production, and decreased peripheral glucose utilization are the core defects responsible for the development and progression of type 2 diabetes. However, the pathophysiology of this disease also includes adipocyte insulin resistance (in...
שמור ב:
| הוצא לאור ב: | Diabetes Spectr |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Diabetes Association
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4522879/ https://ncbi.nlm.nih.gov/pubmed/26246766 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/diaspect.27.2.100 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|